Business Wire

Brazilian National Observatory enhances national timekeeping with Adtran’s Oscilloquartz super high-performance optical cesium clock

Share

News summary: National timekeeping institution sought to enhance stability and precision to support critical national and international scientific work Adtran’s industry-first OSA 3300 SHP with optical pumping technology delivers exceptional short-term stability Deployment ensures consistent, high-precision time synchronization, advancing research, education and contribution to UTC

Adtrantoday announced that the Brazilian National Observatory (Observatório Nacional) has integrated its OSA 3300 Super High-Performance optical cesium atomic clock into its timekeeping infrastructure. The deployment marks the first use of an optical pumping cesium clock at the observatory, enabling it to maintain and distribute legal Brazilian time with unmatched performance. Delivering twice the short and long-term stability of leading magnetic cesium clocks, along with double the operational lifespan, the OSA 3300 SHP ensures consistent, high-precision synchronization that supports both national and regional research and education. The technology solidifies the observatory’s role as a leader in timekeeping and a critical contributor to the global UTC standard.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250204639552/en/

Adtran’s OSA 3300 SHP is helping the Brazilian National Observatory achieve new levels of stability and precision with its timekeeping. (Photo: Business Wire)

“The deployment of Adtran’s Oscilloquartz super high-performance atomic clock is an important step forward in advancing our mission. It empowers us to achieve new levels of stability and precision in maintaining Brazil’s official time, ensuring that our timekeeping meets the highest global standards,” said Ricardo José de Carvalho, head of time service division at the Brazilian National Observatory. “Founded in 1827, our observatory has a long-standing legacy as Brazil’s oldest research institution in astronomy, geophysics and metrology. This new technology strengthens our ability to conduct crucial scientific observations, from seismological monitoring to astronomical data collection. It ensures we’re better equipped to contribute to international scientific collaborations and maintain our status as a leader in the global timekeeping community.”

Adtran’s OSA 3300 SHP cesium atomic clock, the newest addition to the Oscilloquartz synchronization portfolio, is enhancing the capabilities of Brazil’s National Observatory (recognized by lab code ONRJ in the International Bureau of Weights and Measures). As the country’s timekeeping authority, the observatory generates and maintains Brazil’s official time standard, ensuring precise synchronization across critical systems, including telecoms and scientific research. Leveraging industry-first optical pumping technology, the OSA 3300 SHP provides exceptional short-term stability and twice the Allan Deviation performance of the 3300 HP while maintaining the same 10-year lifespan. Its compact design integrates seamlessly into existing systems, ensuring easy deployment. What’s more, its remote management capabilities simplify operations and enhance flexibility for the observatory’s timekeeping infrastructure. Supported by Nextest, a specialized provider of testing and measurement solutions, the deployment will help foster international collaboration in timekeeping and metrology.

“We're helping the Brazilian National Observatory strengthen its role as a leader in timekeeping. Our advanced solution will be key in supporting its efforts to push the boundaries of scientific research, enhance educational programs and contribute valuable data to the global scientific community,” commented Allan De Souza, VP of Latin America sales at Adtran. “Our OSA 3300 SHP cesium atomic clock embodies our dedication to advancing time and frequency technology, built on 75 years of expertise in synchronization solutions. It provides the observatory with unparalleled precision and stability. We’re proud to collaborate with Nextest to support this vital work and contribute to innovations that strengthen timekeeping capabilities worldwide.”

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

About Nextest

Nextest is a Brazilian company based in Minas Gerais specializing in innovative electronic systems, advanced instrumentation, and tailored solutions for various industries. With a strong commitment to quality and customer satisfaction, Nextest leverages cutting-edge technology and technical expertise to deliver reliable products and services. The company has been recognized for its excellence and dedication, being awarded for two consecutive years by Oscilloquartz/Adtran. This prestigious recognition highlights Nextest’s leadership and commitment to delivering exceptional solutions in the field of network synchronization and telecommunications. Find more at Nextest and LinkedIn.

Published by
ADTRAN Holdings, Inc.
www.adtran.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250204639552/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to

Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release

Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further

Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release

New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye